By Mark Melchionna
June 29, 2023 – Driven by its mission of using artificial intelligence (AI)-enhanced technology to support healthcare among older adults, the Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer’s…
Continue Reading
Top News
CMS announces that Medicare Part B will cover the use of FDA-approved monoclonal antibodies to slow the progression of Alzheimer’s disease, but will require doctors to populate patient registries for real-world tracking of…
Continue Reading
David Moss, CFO of INmune Bio
Our brain is an extraordinary organ. This three-pound structure is the central processing unit of our universe that controls intelligence, sense, movement, behavior and much more. When healthy, we…
Continue Reading
Health technology company PicnicHealth, pharma giant Roche and its subsidiary Genentech are expanding their partnership globally to speed up neurological disease research through investments in real-world data.PicnicHealth allows patients to see their health history…
Continue Reading
A study has found that individuals with vascular dementia and atrial fibrillation (AF) have a greater risk of rehospitalization, stroke, and all-cause mortality than those with Alzheimer’s disease and AF, who face a higher…
Continue Reading
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.
Continue Reading
By Shania Kennedy April 17, 2023 – Artificial intelligence can help identify subtle changes in a patient’s voice and speech patterns, which may help clinicians diagnose cognitive impairment and Alzheimer’s disease before symptoms appear, according…
Continue Reading
By Shania Kennedy April 07, 2023 – Researchers at Indiana University (IU) School of Medicine received a 5-year, $41 million grant from the National Institute on Aging (NIA) to fund a study investigating the pathology…
Continue Reading
John Showalter, MD, Chief Product Officer at Linus HealthThe FDA’s recent accelerated approval of Leqembi was welcome news across the Alzheimer’s community. However, few health systems, medical practices, or providers are prepared for the…
Continue Reading
By Mark Melchionna
March 09, 2023 – Published in PLOS ONE, a recent study described how a team of researchers at Massachusetts General Hospital (MGH) developed and validated an artificial intelligence (AI) model, specifically…
